Sign in to follow
Search Results

0 results for 'Celgene Corporation'

You can use to get even better search results
September 01, 2015 |

Cozen Has Quickly Grown a Successful IP Practice

In a little more than 10 years, Cozen O'Connor's intellectual property practice has grown from nothing into a force of nearly 40 attorneys who protect the brands of major companies across a wide variety of industries.
5 minute read
August 31, 2015 | Law.com

Cozen Has Quickly Grown a Successful IP Practice

In a little more than 10 years, Cozen O'Connor's intellectual property practice has grown from nothing into a force of nearly 40 attorneys who protect the brands of major companies across a wide variety of industries.
5 minute read
August 24, 2015 |

Kyle Bass Loses First Round in PTAB

Acorda and lawyer Gerald Flattmann succeeded in fending off an inter partes review petition that was bashed as an attempt to game the stock market.
3 minute read
August 24, 2015 |

Big Deals

9 minute read
July 27, 2015 |

Another Big Deal in Frenzied Pharma Sector

Latham's Charles Ruck, who advised Allergan on the sale of its generics business for $40.5 billion, has been busy.
3 minute read
July 16, 2015 |

This Week's Deals

A round-up of transactions involving Bay Area lawyers and companies.
5 minute read
July 16, 2015 |

Deal Watch: Big Firms Feast on Billionaire's Deal Double

Several Global 100 firms picked up work this week on a pair of acquisitions by companies backed by billionaire Martin Franklin.
5 minute read
July 09, 2015 |

This Week's Deals

A round-up of transactions involving Bay Area lawyers and companies.
8 minute read
July 03, 2015 |

Deal Watch: Skadden Celebrates Holiday Weekend Atop M&A League Tables

M&A league tables for the first half of 2015 compiled by Bloomberg and Thomson Reuters show Skadden, Arps, Slate, Meagher & Flom leading the pack among legal advisers, while several other Am Law 100 firms prepare to fete the Fourth of July with some insurance-related transactional work.
6 minute read
June 22, 2015 |

PTAB Allows Challenge to Investor's Patent Strategy

The Patent Trial and Appeal Board has granted pharmaceutical company Celgene Corp. permission to file a motion for sanctions for abuse of process against an organization created by hedge fund manager Kyle Bass.
3 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources